Metropolitan Life Insurance Company (MetLife)’s Cognyte Software CGNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-18,060
Closed -$502K 2735
2021
Q1
$502K Buy
+18,060
New +$537K 0.01% 1405

Other funds holding CGNT

Metropolitan Life Insurance Company (MetLife)'s CGNT Position: Q2 2021 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Cognyte Software (CGNT) in Q2 2021, closing a stake of 18,060 shares — an estimated $502K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CGNT in Q1 2021 and held it in 1 quarter. The position peaked at $502K in Q1 2021. 176 funds tracked by Wall St. Rank hold CGNT as of Q2 2021.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Cognyte Software position as of Q2 2021 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 18,060 Cognyte Software shares in Q2 2021, an estimated $502K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Cognyte Software in Q1 2021 and held it in 1 quarter.
  • Metropolitan Life Insurance Company (MetLife)'s Cognyte Software position peaked at $502K in Q1 2021.
  • 176 funds tracked by Wall St. Rank held Cognyte Software as of Q2 2021.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2021, filed 16 Aug 2021.